Literature DB >> 22510015

Insights into the different catalytic activities of Clostridium neurotoxins.

Sheng Chen1, Andrew P A Karalewitz, Joseph T Barbieri.   

Abstract

The clostridial neurotoxins are among the most potent protein toxins for humans and are responsible for botulism, a flaccid paralysis elicited by the botulinum toxins (BoNT), and spastic paralysis elicited by tetanus toxin (TeNT). Seven serotypes of botulinum neurotoxins (A-G) and tetanus toxin showed different toxicities and cleave their substrates with different efficiencies. However, the molecular basis of their different catalytic activities with respect to their substrates is not clear. BoNT/B light chain (LC/B) and TeNT light chain (LC/T) cleave vesicle-associated membrane protein 2 (VAMP2) at the same scissile bond but possess different catalytic activities and substrate requirements, which make them the best candidates for studying the mechanisms of their different catalytic activities. The recognition of five major P sites of VAMP2 (P7, P6, P1, P1', and P2') and fine alignment of sites P2 and P3 and sites P2 and P4 by LC/B and LC/T, respectively, contributed to their substrate recognition and catalysis. Significantly, we found that the S1 pocket mutation LC/T(K(168)E) increased the rate of native VAMP2 cleavage so that it approached the rate of LC/B, which explains the molecular basis for the lower k(cat) that LC/T possesses for VAMP2 cleavage relative to that of LC/B. This analysis explains the molecular basis underlying the VAMP2 recognition and cleavage by LC/B and LC/T and provides insight that may extend the pharmacologic utility of these neurological reagents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510015      PMCID: PMC3542401          DOI: 10.1021/bi3000098

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Mechanism of substrate recognition by botulinum neurotoxin serotype A.

Authors:  Sheng Chen; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2007-01-23       Impact factor: 5.157

2.  Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization.

Authors:  Thomas Binz; Steffen Bade; Andreas Rummel; Astrid Kollewe; Jürgen Alves
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

3.  Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Authors:  A Brashear; M F Lew; D D Dykstra; C L Comella; S A Factor; R L Rodnitzky; R Trosch; C Singer; M F Brin; J J Murray; J D Wallace; A Willmer-Hulme; M Koller
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

4.  Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.

Authors:  M Zouhair Atassi; Joseph Jankovic; Lance E Steward; K Roger Aoki; Behzod Z Dolimbek
Journal:  Immunobiology       Date:  2011-08-30       Impact factor: 3.144

5.  Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.

Authors:  M Zouhair Atassi; Behzod Z Dolimbek; Joseph Jankovic; Lance E Steward; K Roger Aoki
Journal:  Mol Immunol       Date:  2008-08-03       Impact factor: 4.407

6.  Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.

Authors:  Sheng Chen; Cherisse Hall; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

7.  Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.

Authors:  Stefan Sikorra; Tina Henke; Thierry Galli; Thomas Binz
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

8.  Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.

Authors:  Sheng Chen; Hoi Ying Wan
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

9.  Unique substrate recognition by botulinum neurotoxins serotypes A and E.

Authors:  Sheng Chen; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2006-02-14       Impact factor: 5.157

10.  Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.

Authors:  Rakhi Agarwal; James J Schmidt; Robert G Stafford; Subramanyam Swaminathan
Journal:  Nat Struct Mol Biol       Date:  2009-06-21       Impact factor: 15.369

View more
  13 in total

Review 1.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

2.  Unique substrate recognition mechanism of the botulinum neurotoxin D light chain.

Authors:  Jiubiao Guo; Sheng Chen
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

Review 3.  Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.

Authors:  Sheng Chen
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

4.  Neuroprotective Effect of Non-viral Gene Therapy Treatment Based on Tetanus Toxin C-fragment in a Severe Mouse Model of Spinal Muscular Atrophy.

Authors:  Sara Oliván; Ana C Calvo; Amaya Rando; Mireia Herrando-Grabulosa; Raquel Manzano; Pilar Zaragoza; Eduardo F Tizzano; Jose Aquilera; Rosario Osta
Journal:  Front Mol Neurosci       Date:  2016-08-24       Impact factor: 5.639

Review 5.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

Review 6.  Fragment C of tetanus toxin: new insights into its neuronal signaling pathway.

Authors:  Ana C Calvo; Sara Oliván; Raquel Manzano; Pilar Zaragoza; José Aguilera; Rosario Osta
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

7.  Structural and functional substrates of tetanus toxin in an animal model of temporal lobe epilepsy.

Authors:  Alex S Ferecskó; Premysl Jiruska; Lucy Foss; Andrew D Powell; Wei-Chih Chang; Attila Sik; John G R Jefferys
Journal:  Brain Struct Funct       Date:  2014-01-18       Impact factor: 3.270

8.  Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.

Authors:  Yongfeng Fan; Jianbo Dong; Jianlong Lou; Weihua Wen; Fraser Conrad; Isin N Geren; Consuelo Garcia-Rodriguez; Theresa J Smith; Leonard A Smith; Mengfei Ho; Melissa Pires-Alves; Brenda A Wilson; James D Marks
Journal:  Toxins (Basel)       Date:  2015-08-26       Impact factor: 4.546

9.  Microbial succession in an inflated lunar/Mars analog habitat during a 30-day human occupation.

Authors:  Teresa Mayer; Adriana Blachowicz; Alexander J Probst; Parag Vaishampayan; Aleksandra Checinska; Tiffany Swarmer; Pablo de Leon; Kasthuri Venkateswaran
Journal:  Microbiome       Date:  2016-06-02       Impact factor: 14.650

10.  Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5.

Authors:  Jiubiao Guo; Edward Wai Chi Chan; Sheng Chen
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.